Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
LIDOCAINE NORIDEM (Interpharma Pty Ltd)
Product name
LIDOCAINE NORIDEM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
117 (255 working days)
Active ingredients
lidocaine (lignocaine) hydrochloride monohydrate
Registration type
New generic medicine
Indication
LIDOCAINE NORIDEM solutions are indicated for the production of local or regional anaesthesia by the following techniques:
- infiltration,
- intravenous regional anaesthesia,
- peripheral nerve block
- epidural block,
- ? subarachnoid block.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine